Psychedelic therapy for body dysmorphic disorder

被引:1
作者
Johnson, Shevaugn [1 ]
Letheby, Chris [2 ,3 ]
机构
[1] Flinders Univ S Australia, Coll Educ Psychol & Social Work, Sturt Rd, Bedford Pk, SA 5042, Australia
[2] Univ Western Australia, Dept Philosophy, 35 Stirling Hwy, Crawley, WA 6009, Australia
[3] Univ Adelaide, Dept Philosophy, North Terrace, Adelaide, SA 5005, Australia
来源
JOURNAL OF PSYCHEDELIC STUDIES | 2022年 / 6卷 / 01期
基金
澳大利亚研究理事会;
关键词
body dysmorphic disorder; classic psychedelic; psilocybin; psychedelic therapy; COGNITIVE-BEHAVIORAL THERAPY; DOUBLE-BLIND; PSILOCYBIN; METAANALYSIS; SEROTONIN; AUGMENTATION; RECOGNITION; EXPERIENCES; PREVALENCE; MODEL;
D O I
10.1556/2054.2022.00200
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this opinion piece we propose the investigation of psychedelic-assisted psychotherapy for the treatment of body dysmorphic disorder (BDD). BDD is a psychiatric disorder characterised by appearance-based preoccupations and accompanying compulsions. While safe and effective treatments for BDD exist, non-response and relapse rates remain high. Therefore, there is a need to investigate promising new treatment options for this highly debilitating condition. Preliminary evidence suggests safety, feasibility, and potential efficacy of psychedelic treatments in disorders that share similar psychopathological mechanisms with BDD. Drawing on this evidence, as well as on relevant qualitative reports and theoretical proposals, we argue that it would be worthwhile to conduct a phase 2a study aimed at assessing the safety and feasibility of psychedelic-assisted psychotherapy in BDD. We also offer some suggestions for how future research ought to proceed.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [41] Body dysmorphic disorder
    Ruck, Christian
    Mataix-Cols, David
    Feusner, Jamie D.
    Shavitt, Roseli Gedanke
    Veale, David
    Krebs, Georgina
    Fernandez de la Cruz, Lorena
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [42] Intolerance of uncertainty in body dysmorphic disorder
    Summers, Berta J.
    Matheny, Natalie L.
    Sarawgi, Shivali
    Cougle, Jesse R.
    BODY IMAGE, 2016, 16 : 45 - 53
  • [43] Exploring the Intersection of Body Dysmorphic Disorder (BDD) and Dermatological Conditions: A Narrative Review
    Li, Vivian
    Frasier, Kelly
    Woolhiser, Emily
    Daly, Kathleen
    Christoforides, Sara
    Harpine, Courtnee
    Stech, Karina
    Acosta, Stefany
    Lephart, Edwin D.
    DERMATOLOGY AND THERAPY, 2024, 14 (10) : 2693 - 2708
  • [44] Pharmacological Treatment of Body Dysmorphic Disorder
    Hong, Kevin
    Nezgovorova, Vera
    Uzunova, Genoveva
    Schlussel, Danya
    Hollander, Eric
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (08) : 697 - 702
  • [45] Status of body dysmorphic disorder in Argentina
    Borda, Tania
    Neziroglu, Fugen
    Santos, Natascha
    Donnelly, Katharine
    Rivera, Ricardo Perez
    JOURNAL OF ANXIETY DISORDERS, 2011, 25 (04) : 507 - 512
  • [46] Pharmacotherapy and psychotherapy for body dysmorphic disorder
    Ipser, Jonathan C.
    Sander, Candice
    Stein, Dan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [47] Cosmetic rhinoplasty in body dysmorphic disorder
    Veale, D
    De Haro, L
    Lambrou, C
    BRITISH JOURNAL OF PLASTIC SURGERY, 2003, 56 (06): : 546 - 551
  • [48] Quality of life in body dysmorphic disorder
    IsHak, Waguih William
    Bolton, Michael A.
    Bensoussan, Jean-Charles
    Dous, GeorgeV.
    Nguyen, Trang T.
    Powell-Hicks, Allycin L.
    Gardner, Jennifer E.
    Ponton, Kimberly M.
    CNS SPECTRUMS, 2012, 17 (04) : 167 - 175
  • [49] Understanding and treating body dysmorphic disorder
    Rossell, Susan
    PSYCHIATRY RESEARCH, 2023, 319
  • [50] Body dysmorphic disorder in pediatric dermatology
    Dennin, Margaret H.
    Lee, Margaret S.
    PEDIATRIC DERMATOLOGY, 2018, 35 (06) : 868 - 874